RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 100 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,951,000 | +12.8% | 652,395 | 0.0% | 0.15% | +37.3% |
| Q4 2021 | $1,729,000 | -27.0% | 652,395 | 0.0% | 0.11% | -23.1% |
| Q3 2021 | $2,368,000 | -16.4% | 652,395 | 0.0% | 0.14% | -8.3% |
| Q2 2021 | $2,831,000 | +26.9% | 652,395 | 0.0% | 0.16% | +22.8% |
| Q1 2021 | $2,231,000 | -36.1% | 652,395 | -34.6% | 0.13% | -30.6% |
| Q4 2020 | $3,494,000 | +22.9% | 998,156 | -15.7% | 0.18% | +17.3% |
| Q3 2020 | $2,842,000 | -56.2% | 1,184,092 | -66.6% | 0.16% | -59.9% |
| Q2 2020 | $6,483,000 | +17.3% | 3,542,551 | 0.0% | 0.39% | -16.0% |
| Q1 2020 | $5,526,000 | -27.1% | 3,542,551 | 0.0% | 0.46% | +11.0% |
| Q4 2019 | $7,581,000 | +13.0% | 3,542,551 | -1.2% | 0.42% | -6.7% |
| Q3 2019 | $6,708,000 | -35.5% | 3,587,351 | -10.0% | 0.45% | -11.7% |
| Q2 2019 | $10,403,000 | +1.6% | 3,985,945 | 0.0% | 0.51% | +18.5% |
| Q1 2019 | $10,244,000 | +11.7% | 3,985,945 | 0.0% | 0.43% | -12.5% |
| Q4 2018 | $9,168,000 | -28.0% | 3,985,945 | +0.5% | 0.49% | -5.2% |
| Q3 2018 | $12,731,000 | +13.4% | 3,966,087 | 0.0% | 0.52% | +14.7% |
| Q2 2018 | $11,224,000 | -20.1% | 3,966,087 | 0.0% | 0.45% | -25.2% |
| Q1 2018 | $14,040,000 | -8.1% | 3,966,087 | +0.8% | 0.60% | -8.8% |
| Q4 2017 | $15,270,000 | +55.9% | 3,935,584 | +2.1% | 0.66% | +59.7% |
| Q3 2017 | $9,792,000 | -7.0% | 3,855,024 | 0.0% | 0.41% | -16.1% |
| Q2 2017 | $10,524,000 | -25.3% | 3,855,024 | -9.4% | 0.49% | -26.3% |
| Q1 2017 | $14,083,000 | +41.7% | 4,254,623 | +1.9% | 0.67% | +17.5% |
| Q4 2016 | $9,940,000 | -47.8% | 4,176,623 | -19.5% | 0.57% | -48.7% |
| Q3 2016 | $19,033,000 | +58.4% | 5,186,088 | -3.7% | 1.11% | +21.9% |
| Q2 2016 | $12,012,000 | +10.4% | 5,386,534 | +3.0% | 0.91% | +7.3% |
| Q1 2016 | $10,880,000 | -31.5% | 5,230,919 | -0.2% | 0.84% | -4.4% |
| Q4 2015 | $15,875,000 | +24.2% | 5,239,119 | +1.2% | 0.88% | +43.7% |
| Q3 2015 | $12,786,000 | -23.1% | 5,176,319 | 0.0% | 0.62% | -16.8% |
| Q2 2015 | $16,616,000 | -10.1% | 5,176,319 | 0.0% | 0.74% | -19.1% |
| Q1 2015 | $18,479,000 | +57.3% | 5,176,319 | 0.0% | 0.91% | +32.5% |
| Q4 2014 | $11,750,000 | +16.9% | 5,176,319 | -0.1% | 0.69% | -8.1% |
| Q3 2014 | $10,049,000 | -46.6% | 5,180,101 | 0.0% | 0.75% | -46.4% |
| Q2 2014 | $18,804,000 | -53.1% | 5,180,101 | -49.9% | 1.40% | -15.6% |
| Q1 2014 | $40,114,000 | +169.8% | 10,338,602 | +98.2% | 1.66% | +19.5% |
| Q4 2013 | $14,868,000 | -34.1% | 5,217,001 | -17.2% | 1.39% | -41.3% |
| Q3 2013 | $22,553,000 | +71.6% | 6,299,664 | +60.1% | 2.36% | +52.4% |
| Q2 2013 | $13,145,000 | – | 3,935,576 | – | 1.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |